| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Shattuck Labs, Inc. (STTK) has 18 insiders with recent SEC Form 4 filings, including 10 buys and 5 sells. STTK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.20M | $45.06M | - | |
| Dir | 3.07M | $19.24M | - | |
| CEO | 1.55M | $9.69M | - | |
| Other | 315.5K | $1.98M | - | |
| CFO | 230.8K | $1.44M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2025 | Ashiya Mona55 | Director | Buy | 6,306,127 | $0.87 | $5,471,826.40 | New | +107.3% | - | |
| Aug 25, 2025 | Orbimed Advisors LLC67 | Director | Buy | 6,306,127 | $0.87 | $5,471,826.40 | New | +107.3% | - | |
| Dec 4, 2024 | Redmile Group, LLC47 | Director, 10% Owner | Sell | 133,371 | $1.25 | $166,713.75 | -2.4% | -1.6% | +137.6% | |
| Dec 4, 2024 | Redmile Group, LLC47 | Director, 10% Owner | Buy | 133,371 | $1.25 | $166,713.75 | +2.5% | -1.6% | +137.6% | |
| Oct 7, 2024 | Schreiber Taylor84 | Chief Executive Officer | Buy | 36,500 | $1.21 | $44,219.75 | +105.8% | +12.4% | +116.8% | |
| Jun 28, 2024 | Brous Tyler | Director | Buy | 8,416 | $3.89 | $32,768.24 | +1.8% | -3.6% | -77.9% | |
| Jun 26, 2024 | Schreiber Taylor84 | Chief Executive Officer | Buy | 14,400 | $3.47 | $50,011.20 | +71.6% | -2.4% | -73.6% | |
| Mar 6, 2024 | Stout Stephen | See Remarks | Sale+OE | 16,004 | $10.53 | $168,522.12 | -6.4% | -24.5% | -86.0% | |
| Jan 10, 2024 | Neill Andrew R86 | Chief Financial Officer | Sell | 25,000 | $10.00 | $250,000.00 | -12.6% | -10.8% | -88.2% | |
| Apr 26, 2022 | Golumbeski George | Director | Buy | 28,330 | $3.63 | $102,837.90 | +107.8% | +16.2% | -20.5% |